Stan Lipkowitz
- Immunology top 2%
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers 3
- HER2/EGFR in Cancer Research 3
- Cancer-related Molecular Pathways 3
- Cancer Research top 5%
- NF-κB Signaling Pathways 6
- Molecular Biology top 5%
- Cell death mechanisms and regulation 6
- Ubiquitin and proteasome pathways 6
- Glycosylation and Glycoproteins Research 2
- Immunology and Allergy top 5%
-
- BRCA gene mutations in cancer 2
- Co-authors
- Seth A. EttenbergMarion M. NauMaccon KeaneMauricio CuelloJosef PenningerE K RussellConnie M. KrawczykPhillip A. Dennis
- Cited by
- ImmunologyOncologyCancer Research
- Journals
- Journal of Clinical Oncology (6 papers)Oncogene (4 papers)Journal of Biological Chemistry (3 papers)
- Partner nations
- United StatesCanadaChile
In The Last Decade
Stan Lipkowitz
29 papers receiving 3.0k citations
Hit Papers
Peers
Comparison fields: 5 of 103
- Immunology 978
- Oncology 1.2k
- Cancer Research 432
- Molecular Biology 1.9k
- Immunology and Allergy 89
Countries citing papers authored by Stan Lipkowitz
This map shows the geographic impact of Stan Lipkowitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stan Lipkowitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stan Lipkowitz more than expected).
Fields of papers citing papers by Stan Lipkowitz
This network shows the impact of papers produced by Stan Lipkowitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stan Lipkowitz. The network helps show where Stan Lipkowitz may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Stan Lipkowitz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Triple negative breast cancer (TNBC): Non-genetic tumor heterogeneity and immune microenvironment: Emerging treatment optionsbreakdown → | 2022 | 143 |
| 2 | 2020 | 3 | |
| 3 | 2016 | 3 | |
| 4 | 2004 | 71 | |
| 5 | 2004 | 149 | |
| 6 | 2004 | 96 | |
| 7 | 2004 | 149 | |
| 8 | 2004 | 89 | |
| 9 | 2003 | 144 | |
| 10 | 2003 | 39 | |
| 11 | 2002 | 45 | |
| 12 | 2001 | 125 | |
| 13 | Down-regulation of the erbB-2 receptor by trastuzumab (herceptin) enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in breast and ovarian cancer cell lines that overexpress erbB-2. | 2001 | 301 |
| 14 | 2001 | 136 | |
| 15 | Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-bbreakdown → | 2000 | 553 |
| 16 | 2000 | 87 | |
| 17 | 1999 | 103 | |
| 18 | 1999 | 96 | |
| 19 | 1997 | 69 | |
| 20 | The protein tyrosine phosphatase DEP-1 is induced during differentiation and inhibits growth of breast cancer cells. | 1996 | 115 |
About Stan Lipkowitz
Stan Lipkowitz is a scholar working on Cancer Research, Aging and Oncology, having authored 29 papers that have together received 3.0k indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (6 papers), Ubiquitin and proteasome pathways (6 papers), NF-κB Signaling Pathways (6 papers), Cancer Immunotherapy and Biomarkers (3 papers), HER2/EGFR in Cancer Research (3 papers), Cancer-related Molecular Pathways (3 papers), Glycosylation and Glycoproteins Research (2 papers) and BRCA gene mutations in cancer (2 papers). The work is most often cited by research in Immunology (978 citations), Oncology (1.2k citations) and Cancer Research (432 citations). Stan Lipkowitz has collaborated with scholars based in United States, Canada and Chile. Frequent co-authors include Seth A. Ettenberg, Marion M. Nau, Maccon Keane, Mauricio Cuello, Josef Penninger, E K Russell, Connie M. Krawczyk, Phillip A. Dennis, Amy S. Clark and Joyce E. Ohm. Their work appears in journals such as Journal of Clinical Oncology, Oncogene, Journal of Biological Chemistry, Cancer Research and Cancer Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.